Websites hosted on 12.3.33.225 IP Address
Geo Location Information for 12.3.33.225 IP Address. The IP Address 12.3.33.225 is located at 40.2684 latitude and -75.3903 longitude in United States of America. Friendly Location for the IP Address is Pennsylvania, Harleysville, United States, 19438.
Global Rare Disease Biotech Company | CSL Behring
CSL Behring is a leading global biotech company driven by its promise to save and improve lives. We manufacture remedies for serious and rare diseases.
Not Applicable
$
8.95
Home | Kcentra® (Prothrombin complex concentrate [human])
Learn about Kcentra 4F-PCC, FDA - approved for urgent warfarin reversal.
Not Applicable
$
8.95
ZEMAIRA® (Alpha1-Proteinase Inhibitor) | Patient Website
Learn about living with Alpha-1, along with the augmentation therapy and benefits that ZEMAIRA has to offer patients.
5,599,281
$
240.00
Hereditary Bleeding Disorders
CSL Behring has developed several plasma-derived therapies for treating hereditary bleeding disorders. Learn more.
Not Applicable
$
8.95
ZEMAIRA® (Alpha1-Proteinase Inhibitor) | Patient Website
Learn about living with Alpha-1, along with the augmentation therapy and benefits that ZEMAIRA has to offer patients.
Not Applicable
$
8.95
Portraits of Progress | Hemophilia Treatment Evolution
Portraits of Progress is an exploration of hemophilia history and lived experiences of patients, caregivers, and professionals impacted by the disorder.
Not Applicable
$
8.95
Portraits of Progress | Hemophilia Treatment Evolution
Portraits of Progress is an exploration of hemophilia history and lived experiences of patients, caregivers, and professionals impacted by the disorder.
Not Applicable
$
8.95
Global Biotechnology Company | CSL
CSL Seqirus one of the largest influenza vaccine providers in the world and a major contributor to the prevention of influenza globally and a transcontinental partner in pandemic preparedness.
Not Applicable
$
8.94
FLUCELVAX® QUADRIVALENT (Influenza Vaccine) | CSL Seqirus flu360
FLUCELVAX® QUADRIVALENT is the first and only FDA-approved cell-based seasonal influenza vaccine in the US. Visit flu360.com to learn more.
Not Applicable
$
8.94
FLUAD® QUADRIVALENT (Influenza Vaccine, Adjuvanted) for 65+ | CSL Seqi
FLUAD® QUADRIVALENT with MF59® Adjuvant is a flu vaccine designed to strengthen, broaden, and lengthen the duration of the immune response and is approved for patients 65+. Visit flu360.com to learn more.
Not Applicable
$
8.94
